<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767783/" ref="ordinalpos=1321&amp;ncbi_uid=5295103&amp;link_uid=PMC3767783" image-link="/pmc/articles/PMC3767783/figure/pone-0072999-g006/" class="imagepopup">Figure 6. E2, G1 and OHT promoted cell migration through the GPR30/EGFR/PI3K/ERK/FAK <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>..  From: Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor ? (ER?). </a></div><br /><div class="p4l_captionBody">Our current model of activation of the GPR30-EGFR-PI3K-ERK-FAK pathway by E2, G1 and OHT.</div></div>